Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank67
Studio
Year-over-Year Change

Free cash flow yield

Latest
-2.11%
↑ 74% vs avg
Percentile
P67
Within normal range
Streak
1 yr
Consecutive declineElevated
Average
-8.08%
Historical baseline
PeriodValueYoY Change
2025-2.11%-128.5%
20247.41%+134.2%
2023-21.64%+26.2%
2022-29.32%-303.2%
2021-7.27%-156.3%
2020-2.84%-249.9%
2019-0.81%-